Calithera Biosciences cancels special meeting due to lack of quorum
| CALADelisted Stock | USD 0.05 0.00 0.00% |
About 56% of Calithera Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Calithera Biosciences pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Calithera Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Calithera Biosciences stock news signals to limit their universe of possible portfolio assets.
Calithera |
Calithera Biosciences said Thursday it was unable to achieve a quorum of stockholders at its special meeting to approve its plan of complete liquidation and dissolution
Read at seekingalpha.com
 |
Calithera Biosciences Fundamental Analysis
We analyze Calithera Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Calithera Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Calithera Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Calithera Biosciences is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Calithera Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Calithera Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Calithera Biosciences could also be used in its relative valuation, which is a method of valuing Calithera Biosciences by comparing valuation metrics with similar companies.
Peers
Calithera Biosciences Related Equities
| KOD | Kodiak Sciences | 11.39 | ||||
| ADVM | Adverum Biotechnologies | 3.61 | ||||
| VSTM | Verastem | 3.37 | ||||
| GLMD | Galmed Pharmaceuticals | 2.80 | ||||
| PIRS | Pieris Pharmaceuticals | 1.11 | ||||
| MREO | Mereo BioPharma | 0.55 | ||||
| ABEO | Abeona Therapeutics | 0.78 | ||||
| ADAP | Adaptimmune Therapeutics | 1.37 | ||||
| CKPT | Checkpoint Therapeutics | 1.82 | ||||
| PDSB | PDS Biotechnology | 1.83 | ||||
| AFMD | Affimed NV | 2.11 | ||||
| ARDX | Ardelyx | 2.29 | ||||
| LPTX | Leap Therapeutics | 2.68 | ||||
| HEPA | Hepion Pharmaceuticals | 5.97 | ||||
| ZURA | Zura Bio | 8.20 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Calithera Pink Sheet
If you are still planning to invest in Calithera Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calithera Biosciences' history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |